Diplomat Provides 2016 Financial Guidance Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
Diplomat Pharmacy (DPLO) PT Cut to $14 at Cowen
January 10, 2017 8:58 AM ESTCowen lowered its price target on Diplomat Pharmacy (NYSE: DPLO) to $14.00 (from $18.00) as the company expects 2016 results to come in towards the lower-end of guidance.
Analyst Charles Rhyee commented, "DPLO now expects 2016 results to come in towards the lower-end of guidance. More... More



